iQ Biosciences performs contract research for routine Testing Services, Drug Discovery, Safety Assessment, and Preclinical Studies that can help determine your therapeutic candidate safety, bioactivity, and mechanism of action. These services include testing services, in-vitro based safety assessment assays, and functional characterization using in-vitro assays or in-vivo pharmacology models. Please contact us if you are interested in specific assays or models related to the following areas:
iQ currently provides the following Safety Assessment services: Hemolysis Assay, Cytokine Release Assay, and Immune Monitoring (immunophenotyping).
We currently offer the following in-vitro assays: Antibody-dependent cell-mediated cytotoxicity (ADCC), Complement Dependent Cytotoxicity (CDC), and Antibody drug conjugate cytotoxicity (ADC).
iQ offers the following immuno-oncology bioservices: Immune Checkpoint Functional Assay, Immune Checkpoint Interaction Assay.